CN1151312A - Hepatitis C capsule and its prepn. method - Google Patents
Hepatitis C capsule and its prepn. method Download PDFInfo
- Publication number
- CN1151312A CN1151312A CN 96110263 CN96110263A CN1151312A CN 1151312 A CN1151312 A CN 1151312A CN 96110263 CN96110263 CN 96110263 CN 96110263 A CN96110263 A CN 96110263A CN 1151312 A CN1151312 A CN 1151312A
- Authority
- CN
- China
- Prior art keywords
- parts
- hepatitis
- portions
- radix
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine in the form of capsule for curing hepatitis C with obvious curative effect is prepared from 10 Chinese-medicinal materials such as giant knotweed rhizome, oriental wormwood, schisandra fruit, dandelion herb, scutellaria root, etc. through proportioning, decocting three times, merging filtered liquid, filter, concentration, granulating, drying, and preparing capsules.
Description
The present invention relates to a kind of Chinese medicine for the treatment of hepatitis C, particularly a kind of hepatitis C capsule and preparation method thereof.
Hepatitis C is just find in recent years a kind of by the infectious disease of blood transfusion.Its various Signs and index are close with hepatitis B patient, and infection rate increases year by year.Adopt biological product treatment hepatitis C such as interferon at present both at home and abroad more, but because patient's sensitivity is low, the relapse rate height, cost an arm and a leg, side effect is big, and long term injections is brought unlimited misery to the patient, and interferon is developed according to the west ethnic group, so cure rate is extremely low, so the people who adopts is fewer and feweri.
The objective of the invention is to provide a kind of and can purify the blood, sharp temperature toxin expelling, few side effects, cheap, can reach hepatitis C capsule of radical cure purpose and preparation method thereof.
The object of the present invention is achieved like this.Hepatitis C that modern medicine is referred to as does not have this title, but with regard to its clinical findings sings and symptoms, can be summarized in the category of motherland's medical science " jaundice " and " hypochondriac pain ", " gathering " in motherland's medical literature.Its etiology and pathogenesis is general many owing to eating and drinking without temperance, the delicious food of being addicted to drink, and the heresy that diseases caused by exogenous pathogenic factor epidemic disease poison is warm, it is impaired to cause spleen and stomach function, dysfunction of the spleen in transportation, retention of dampness in middle-JIAO.Accumulate and steam in liver and gall, the liver failing to maintain the normal flow of QI, bile is excessive, impregnated in skin, and is dirty in bladder, forms jaundice.Side of body rib is the dividing line of liver and gall, and so hot and suffocating, the functional activity of QI being not smooth of liver and gall is distending pain over the hypochondrium.According to determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, be method with clearing away heat-damp and promoting diuresis, regulating liver-QI reason spleen to its rule of treatment of this damp-heat syndrome.
Medicine of the present invention is made (consumption is a weight portion) by following component:
20～30 parts of 20～30 parts of Herba Taraxacis of 20～30 parts of Fructus Schisandrae Chinensis of 20～30 portions of Herba Artemisiae Scopariaes of Rhizoma Polygoni Cuspidati
20～30 parts of 15～25 parts of Radix Salviae Miltiorrhizaes of 15～25 portions of Radix Paeoniae Albas of 10～20 parts of Fructus Lyciis of Radix Scutellariae
8～15 parts in 10～20 portions of Radix Glycyrrhizaes of Poria
The optimum weight proportioning of medicine of the present invention is:
15 parts of 25 parts of Radix Scutellariaes of 25 parts of Herba Taraxacis of 25 parts of Fructus Schisandrae Chinensis of 25 portions of Herba Artemisiae Scopariaes of Rhizoma Polygoni Cuspidati
10 parts in 15 portions of Radix Glycyrrhizaes of 25 parts of Poria of 20 parts of Radix Salviae Miltiorrhizaes of 20 portions of Radix Paeoniae Albas of Fructus Lycii
The production method of above-mentioned each component being made medicine of the present invention is:
Get above ten flavor Chinese medicines and give as one thinks fit cataclasmly, decoct with water first, second time 2 hours, 1 hour for the third time three times, merging filtrate filters, and filtrate is concentrated into the clear paste and the appropriate amount of starch mixing of relative density 1.30～1.35 (50 ℃), add 90% ethanol and granulate in right amount, drying incapsulates promptly.
Hepatitis C capsule is from clinical proved recipe, belongs to domestic initiation, is development and coming on the basis of treatment hepatitis B.Hepatitis C is many by blood transfusion or hepatitis B and due to developing.According to these characteristics, we adopt Chinese herbal treatment, make all medicines go into blood system, purify the blood, and the dampness removing toxin expelling, thus reach the purpose of radical cure.
Function of the present invention with cure mainly: clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body, regulating liver-QI reason spleen.
Usage and consumption: oral, one day twice, each 3-5 grain.
Embodiment.Press routine proportioning and take by weighing raw material:
25 kilograms of 25 kilograms of Herba Taraxacis of 25 kilograms of Fructus Schisandrae Chinensis of 25 kilograms of Herba Artemisiae Scopariaes of Rhizoma Polygoni Cuspidati
25 kilograms of 20 kilograms of Radix Salviae Miltiorrhizaes of 20 kilograms of Radix Paeoniae Albas of 15 kilograms of structure Fructus Lyciis of Radix Scutellariae
10 kilograms in 15 kilograms of Radix Glycyrrhizaes of Poria
Production method: get above ten flavor Chinese medicines and give as one thinks fit cataclasm, decoct with water three times, first, second time 2 hours, 1 hour for the third time, merging filtrate filtered, filtrate is concentrated into the clear paste and the appropriate amount of starch mixing of relative density 1.30～1.35 (50 ℃), add 90% ethanol and granulate in right amount, drying incapsulates promptly.
Claims (4)
1, a kind of Chinese medicine-hepatitis C capsule for the treatment of hepatitis C is characterized in that it is the medicament of being made by the following weight proportion raw material
20～30 parts of 20～30 parts of Herba Taraxacis of 20～30 parts of Fructus Schisandrae Chinensis of 20～30 portions of Herba Artemisiae Scopariaes of Rhizoma Polygoni Cuspidati
20～30 parts of 15～25 parts of Radix Salviae Miltiorrhizaes of 15～25 portions of Radix Paeoniae Albas of 10～20 parts of Fructus Lycii of Radix Scutellariae
8～15 parts in 10～20 portions of Radix Glycyrrhizaes of Poria
2, hepatitis C capsule according to claim 1 wherein the weight proportion of each raw material be
25 parts of 25 parts of Herba Taraxacis of 25 parts of Fructus Schisandrae Chinensis of 25 portions of Herba Artemisiae Scopariaes of Rhizoma Polygoni Cuspidati
25 parts of 20 parts of Radix Salviae Miltiorrhizaes of 20 portions of Radix Paeoniae Albas of 15 parts of Fructus Lycii of Radix Scutellariae
10 parts in 15 portions of Radix Glycyrrhizaes of Poria
3, require 1,2 described hepatitis C capsules according to weighing, it is characterized in that said medicament is a said capsule on a kind of pharmaceutics.
4, the preparation method of hepatitis C capsule according to claim 3 is characterized in that: get above ten flavor Chinese medicines and give as one thinks fit cataclasm, decoct with water three times, the first, 2 hours for the second time, 1 hour for the third time, merging filtrate, filter, filtrate is concentrated into the clear paste and the appropriate amount of starch mixing of relative density 1.30～1.35 (50 ℃), add 90% ethanol and granulate in right amount, drying incapsulates promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96110263 CN1151312A (en) | 1996-07-14 | 1996-07-14 | Hepatitis C capsule and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96110263 CN1151312A (en) | 1996-07-14 | 1996-07-14 | Hepatitis C capsule and its prepn. method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1151312A true CN1151312A (en) | 1997-06-11 |
Family
ID=5120803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96110263 Pending CN1151312A (en) | 1996-07-14 | 1996-07-14 | Hepatitis C capsule and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1151312A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002032444A1 (en) * | 2000-10-18 | 2002-04-25 | Wu, Bertolotti, Jy-Yuan | Novel medicinal herbal composition for treating liver diseases and hiv |
| CN1110314C (en) * | 1999-01-21 | 2003-06-04 | 赵承文 | Recovery powder for heptitis C |
| US6696094B2 (en) | 2000-10-18 | 2004-02-24 | Tzu-Sheng Wu | Herbal pharmaceutical composition for treatment of HIV/AIDS patients |
| WO2005079823A1 (en) * | 2004-02-19 | 2005-09-01 | Phynova Limited | Plant-based medicament for the treatment of hepatitis c |
| WO2007020382A3 (en) * | 2005-08-12 | 2007-05-31 | Phynova Ltd | Plant-based medicament for the treatment of liver disease |
| CN103736031A (en) * | 2014-01-23 | 2014-04-23 | 荆霞 | Drug for treating viral hepatitis type C and preparation method thereof |
-
1996
- 1996-07-14 CN CN 96110263 patent/CN1151312A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110314C (en) * | 1999-01-21 | 2003-06-04 | 赵承文 | Recovery powder for heptitis C |
| WO2002032444A1 (en) * | 2000-10-18 | 2002-04-25 | Wu, Bertolotti, Jy-Yuan | Novel medicinal herbal composition for treating liver diseases and hiv |
| US6455078B1 (en) * | 2000-10-18 | 2002-09-24 | Tzu-Sheng Wu | Medicinal herbal composition for treating liver diseases and HIV |
| US6696094B2 (en) | 2000-10-18 | 2004-02-24 | Tzu-Sheng Wu | Herbal pharmaceutical composition for treatment of HIV/AIDS patients |
| WO2005079823A1 (en) * | 2004-02-19 | 2005-09-01 | Phynova Limited | Plant-based medicament for the treatment of hepatitis c |
| JP2007523144A (en) * | 2004-02-19 | 2007-08-16 | ファイノバ・リミテッド | Botanical medicine for treating hepatitis C |
| US7422760B2 (en) | 2004-02-19 | 2008-09-09 | Phynova Limited | Plant-based medicament for the treatment of Hepatitis C |
| EA014234B1 (en) * | 2004-02-19 | 2010-10-29 | Финова Лимитед | Composition for the treatment of hepatitis c or dietary supplement for prevention or alleviation hepatitis c symptoms |
| WO2007020382A3 (en) * | 2005-08-12 | 2007-05-31 | Phynova Ltd | Plant-based medicament for the treatment of liver disease |
| CN103736031A (en) * | 2014-01-23 | 2014-04-23 | 荆霞 | Drug for treating viral hepatitis type C and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN1062157C (en) | Hepatitis B curing toxin-dissipating pill | |
| CN102397372A (en) | Pharmaceutical composition, preparation and application of pharmaceutical composition in treating irritable bowel syndrome | |
| CN1151312A (en) | Hepatitis C capsule and its prepn. method | |
| CN101524502A (en) | Chinese medicinal composition for treating blood lipid reduction | |
| CN1145240A (en) | Medicinal compsn. for prevention of Aids virus and cancer | |
| CN101347605B (en) | Traditional Chinese medicine composition for treating gout and preparation method and application thereof | |
| CN101209287A (en) | Heat-clearing and detoxication antiphlogistic detumescence Chinese medicinal composition and preparation thereof | |
| CN101548993B (en) | Application of Japanese climbing fern spore in preparing lead excretion medicines or health products | |
| CN1582985A (en) | Medicine for diabetes and its preparation | |
| CN1049128C (en) | Antidiarrheal powder for baby | |
| CN1133718A (en) | Medicine for treatment of gastrosis and its preparing process | |
| CN1045388C (en) | Four-herb protein reducing soup for treatment of proteinuria caused by acute and chronic nephritis and producing method thereof | |
| CN1827138A (en) | Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof | |
| CN1695639A (en) | Chinese traditional medicine for treating dysmenorrhea and irregular menses, and preparation method | |
| KR20040004822A (en) | A composition comprising the extract of herb medicines for enhancing immunity and a medical wine using the composition | |
| CN1943682A (en) | A Chinese traditional medicinal composition for treatment of hepatitis C | |
| CN102397430B (en) | Cinobufotalin liver nourishing capsules | |
| CN102068669B (en) | Medicament for treating infant hepatitis syndrome, and preparation method and quality control method thereof | |
| CN1094358C (en) | Hypoglycemic medicine composition | |
| CN1036503C (en) | Medicine for treating systemic lupus erythematosus and producing method thereof | |
| CN1049834C (en) | Medicine for curing hepatitis and its prepn process | |
| CN100335095C (en) | Jierening Granule for abating fever and its preparation | |
| CN101313972A (en) | Technique for preparing new preparation of six ingredients with rehmannia | |
| CN1393255A (en) | Medicine for treating viral hepatitis C |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |